NCT03649971 2025-02-03
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Janssen Research & Development, LLC
Phase 1 Completed
Clinical Trials
4 trialsNCT05014360 2023-06-02
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
Janssen Research & Development, LLC
Phase 1 Completed
NCT01483144 2021-06-08
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Cancer Prevention Pharmaceuticals, Inc.
Phase 3 Completed
NCT00510692 2014-08-22
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
S.L.A. Pharma AG
Phase 2/3 Completed